Pharmaceutical manufacturing

May 11, 2019 - 1:16 pm
BOSTON (AP) — Attorneys general from more than 40 states are alleging the nation's largest generic drug manufacturers conspired to artificially inflate and manipulate prices for more than 100 different generic drugs, including treatments for diabetes, cancer, arthritis and other medical conditions...
Read More
President Donald Trump speaks during a event on medical billing, in the Roosevelt Room of the White House, Thursday, May 9, 2019, in Washington. (AP Photo/Evan Vucci)
May 09, 2019 - 12:59 pm
WASHINGTON (AP) — The Latest on President Donald Trump's effort to limit "surprise medical bills" (all times local): 1 p.m. President Donald Trump is ratcheting up pressure on the pharmaceutical industry to lower prices and announcing a new effort to end "surprise medical bills" for patients with...
Read More
FILE - In this March 13, 2019, file phtooHealth and Human Services Secretary Alex Azar testifies before a House Appropriations subcommittee on Capitol Hill in Washington. Azar says drugmakers will soon have to reveal prices of their prescription medicines in those ever-present TV ads. The Trump administration will issue final regulations on May 8 requiring drug companies to disclose list prices of medications costing more than $35 for a month’s supply. Azar tells The Associated Press if drugmakers are scared to put prices in ads that means they should lower those prices. (AP Photo/Susan Walsh, File)
May 08, 2019 - 10:01 am
WASHINGTON (AP) — Those ever-present TV ads for prescription drugs will soon carry prices, too, the nation's top health official said Wednesday, responding to a public outcry for government action to restrain medication costs. Health and Human Services Secretary Alex Azar said the Trump...
Read More
A report released on Thursday, May 2, 2019, by the Congressional Budget Office is photographed in Washington. Budget experts for Congress say the Trump administration’s plan to reduce out-of-pocket drug costs for Medicare beneficiaries will cost taxpayers another $177 billion from 2020-2029. (AP Photo/Jon Elswick)
May 02, 2019 - 7:49 pm
WASHINGTON (AP) — The Trump administration's plan to ease the financial hit of prescription drugs prices for Medicare beneficiaries will cost taxpayers another $177 billion over 10 years, congressional budget experts said on Thursday. The estimates from the nonpartisan Congressional Budget Office...
Read More
In this Friday, April 26, 2019 photo, a box of RELPAX migraine pills manufactured by Pfizer are arranged for a photo in Doral, Fla. Pfizer Inc. reports financial results Tuesday, April 30. (AP Photo/Wilfredo Lee)
April 30, 2019 - 3:27 pm
Higher prescription drugs sales and restrained spending together gave drugmaker Pfizer a 9% jump in first quarter profit as it easily topped analysts' profit expectations. Investors drove up Pfizer shares $1.20, or 3%, to $40.79 in early afternoon trading. Sales of breast cancer drug Ibrance and...
Read More
FILE- This May 1, 2018, file photo shows Merck corporate headquarters in Kenilworth, N.J. Merck & Co. reports financial results Tuesday, April 30, 2019. (AP Photo/Seth Wenig, File)
April 30, 2019 - 7:23 am
KENILWORTH, N.J. (AP) — Merck is breezing past all expectations for the first quarter with global sales jumping 8 percent to almost $11 billion. The New Jersey drugmaker on Tuesday said it earned $2.92 billion, or $1.12 per share. Earnings, adjusted for one-time gains and costs, were $1.22 per...
Read More
FILE - This Feb. 6, 2015, file photo shows a measles, mumps and rubella vaccine on a countertop at a pediatrics clinic in Greenbrae, Calif. Hundreds of opponents of mandatory vaccines are opposing a California proposal to give state public health officials instead of local doctors the power to decide which children can skip their shots before attending school. They plan to pack the first legislative hearing Wednesday, April 24, 2019 on a bill that proponents say would stem bogus exemptions granted in many cases by doctors who are paid to excuse students from vaccinations. Supporters say pockets of unvaccinated students help to spread measles. (AP Photo/Eric Risberg, File)
April 24, 2019 - 6:14 pm
SACRAMENTO, Calif. (AP) — Hundreds of critics of mandatory vaccines were in Sacramento Wednesday opposing a California proposal to give state public health officials instead of local doctors the power to decide which children can skip their shots before attending school. They packed the first...
Read More
FILE - In this Oct. 30, 2009 file photo, a mother holds her baby receiving a new malaria vaccine as part of a trial at the Walter Reed Project Research Center in Kombewa in Western Kenya. The World Health Organization said Tuesday April 23, 2019, that Malawi has become the first country to introduce a pilot program vaccinating children against malaria using the only licensed vaccine to protect against the mosquito-spread disease. Although the vaccine only protects about one third of children who are immunized, those who get the shot are likely to have less severe cases of malaria. (AP Photo/Karel Prinsloo, File)
April 23, 2019 - 3:52 pm
LONDON (AP) — The World Health Organization says Malawi has become the first country to begin immunizing children against malaria, using the only licensed vaccine to protect against the mosquito-spread disease. Although the vaccine only protects about one-third of children who are immunized, those...
Read More
FILE - This Friday, Oct. 10, 2008, file photo illustration shows Johnson & Johnson products, in Philadelphia. Johnson & Johnson is topping profit and revenue expectations for the first quarter partially on strong sales of its psoriasis treatment, Stelara. The New Brunswick, N.J., company on Tuesday, April 16, 2019 posted profit of $3.75 billion, or $1.39 per share. Earnings, adjusted for amortization costs and research and development costs, were $2.10 per share, or 7 cents better that Wall Street expected, according to a survey by Zacks Investment Research. (AP Photo/Matt Rourke, File)
April 16, 2019 - 8:04 am
Lower sales overseas and higher costs for research and litigation pushed Johnson & Johnson's first-quarter profit down 14%, but the health care giant still beat profit and revenue expectations. The maker of Tylenol and psoriasis drug Stelara on Tuesday said unfavorable currency exchange rates...
Read More
Prime Therapeutics Senior Vice President, General Counsel, and Interim President and Chief Executive Officer Mike Kolar, right, testifies before the Senate Finance Committee on Capitol Hill in Washington, Tuesday, April 9, 2019, during a hearing to explore the high cost of prescription drugs. He is joined at the table by, from left, Cigna Corporation Executive Vice President and Chief Clinical Officer Steve Miller, CVS Caremark President and CVS Health Executive Vice President Derica Rice, Humana Healthcare Services Segment President William Fleming and OptumRx Chief Executive Officer John Prince. (AP Photo/Susan Walsh)
April 09, 2019 - 2:29 pm
Patient bills, competition and secrecy shared the spotlight Tuesday as pharmacy benefit managers testified before Congress about prescription drug prices. Members of a Senate Finance Committee investigating drug costs pushed the benefit managers to explain why they can't do more to control prices...
Read More

Pages